PubRank

E Földes-Filep

Author PubWeight™ 17.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation 1997 1.86
2 Leukotriene B4 receptors on guinea pig alveolar eosinophils. J Pharmacol Exp Ther 1991 1.00
3 Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. Br J Pharmacol 1993 0.98
4 Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor. Life Sci 1989 0.98
5 Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol 1992 0.97
6 Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors. Br J Pharmacol 1995 0.96
7 Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat. Br J Pharmacol 1987 0.93
8 Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors. Br J Pharmacol 1993 0.91
9 Nitric oxide modulates vascular permeability in the rat coronary circulation. Br J Pharmacol 1993 0.90
10 Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol 1993 0.88
11 Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2. Br J Pharmacol 1994 0.88
12 Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat. Br J Pharmacol 1994 0.87
13 C-reactive protein inhibits binding of platelet-activating factor to human platelets. Thromb Res 1991 0.85
14 Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat. Br J Pharmacol 1995 0.83
15 Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor. Br J Pharmacol 1992 0.81
16 Effect of urinary pH and urine flow rate on prostaglandin E2 and kallikrein excretion by the conscious dog. J Physiol 1987 0.80
17 Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophil granulocytes. Eur J Pharmacol 1990 0.80
18 Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists. Am J Physiol 1987 0.79
19 Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat. Br J Pharmacol 1996 0.75
20 Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system. J Cardiovasc Pharmacol 1987 0.75
21 Leukotrienes do not modify the effects of PAF on human platelet aggregation. Thromb Res 1987 0.75